CLINICAL-PHARMACOLOGY OF POLYESTRADIOL PHOSPHATE

被引：8

作者：

GUNNARSSON, PO ^{[1
]}

NORLEN, BJ ^{[1
]}

机构：

[1] UNIV UPPSALA HOSP,DEPT UROL,S-75014 UPPSALA,SWEDEN

来源：

关键词：

D O I：

10.1002/pros.2990130405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：299 / 304

页数：6

共 11 条

[1] ANDERSSON S B, 1981, European Journal of Drug Metabolism and Pharmacokinetics, V6, P149
[2] CARLSTROM K, 1989, IN PRESS PROSTATE
[3] DICZFALUSY E, 1956, ACTA ENDOCRINOL-COP, V21, P312
[4] ELLIS WJ, 1985, CANCER RES, V45, P6041
[5] HIGH MOLECULAR WEIGHT ENZYME INHIBITORS .3. POLYESTRADIOL PHOSPHATE (PEP), A LONG-ACTING ESTROGEN
FERNO, O
FEX, H
HOGBERG, B
LINDEROT, T
VEIGE, S
[J]. ACTA CHEMICA SCANDINAVICA, 1958, 12 (08): : 1675 - 1689
[6] CARDIOVASCULAR FOLLOW-UP OF PATIENTS WITH PROSTATIC-CANCER TREATED WITH SINGLE-DRUG POLYESTRADIOL PHOSPHATE
HENRIKSSON, P
ERIKSSON, A
STEGE, R
COLLSTE, L
POUSETTE, A
VONSCHOULTZ, B
CARLSTROM, K
[J]. PROSTATE, 1988, 13 (03) : 257 - 261
[7] Jonsson G, 1975, Vitam Horm, V33, P351
[8] LEINONEN P, 1979, INVEST UROL, V17, P24
[9] NORLEN BJ, 1987, EUR UROL, V13, P193
[10] STEGE R, 1989, IN PRESS PROSTATE